Andreas Kaubisch, MD, discusses the phase III REACH and REACH-2 trials in advanced hepatocellular carcinoma.
Andreas Kaubisch, MD
Advertisement
Articles by Andreas Kaubisch, MD
Andreas Kaubisch, MD, discusses available treatment options for hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Dr. Kaubisch on Treatment Options for HCCNovember 1st 2019
Dr. Kaubisch on the REACH Trials in HCCNovember 20th 2019
Advertisement
Advertisement
Trending on OncLive
1
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
2
From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving
3
The OncFive: Top Oncology Articles for the Week of 5/31
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5